Cargando…

Nationwide Experience of Treatment with Protease Inhibitors in Chronic Hepatitis C Patients in Denmark: Identification of Viral Resistance Mutations

BACKGROUND AND AIMS: The first standard of care in treatment of chronic HCV genotype 1 infection involving directly acting antivirals was protease inhibitors telaprevir or boceprevir combined with pegylated-interferon and ribavirin (triple therapy). Phase III studies include highly selected patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sølund, Christina, Krarup, Henrik, Ramirez, Santseharay, Thielsen, Peter, Røge, Birgit T., Lunding, Suzanne, Barfod, Toke S., Madsen, Lone G., Tarp, Britta, Christensen, Peer B., Gerstoft, Jan, Laursen, Alex L., Bukh, Jens, Weis, Nina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249835/ https://www.ncbi.nlm.nih.gov/pubmed/25438153 http://dx.doi.org/10.1371/journal.pone.0113034

Ejemplares similares

Ischemic Heart Disease in Chronic Hepatitis B: A Danish Nationwide Cohort Study
por: Lau, Frederik Faergemann, et al.
Publicado: (2022)

Incidence of Hepatocellular Carcinoma and Decompensated Liver Cirrhosis and Prognostic Accuracy of the PAGE-B HCC Risk Score in a Low Endemic Hepatitis B Virus Infected Population
por: Bollerup, Signe, et al.
Publicado: (2022)

Liver-related morbidity and mortality in patients with chronic hepatitis C and cirrhosis with and without sustained virologic response
por: Hallager, Sofie, et al.
Publicado: (2017)

Genetic Variants in the Apoptosis Gene BCL2L1 Improve Response to Interferon-Based Treatment of Hepatitis C Virus Genotype 3 Infection
por: Clausen, Louise Nygaard, et al.
Publicado: (2015)

Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAs
por: Søholm, Jacob, et al.
Publicado: (2020)

Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: A Danish nationwide cohort study
por: Hansen, Nanna, et al.
Publicado: (2011)

The Prevalence of Human Immunodeficiency Virus Coinfection Among Patients Newly Diagnosed With Chronic Hepatitis B or C in Denmark: A Nationwide Cohort Study
por: Hallager, Sofie, et al.
Publicado: (2018)

A multi-level intervention to eliminate hepatitis C from the Region of Southern Denmark: the C-Free-South project
por: Dröse, Sandra, et al.
Publicado: (2022)

Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape Variants
por: Jensen, Sanne Brun, et al.
Publicado: (2019)

Neutralizing Antibodies in Patients with Chronic Hepatitis C, Genotype 1, against a Panel of Genotype 1 Culture Viruses: Lack of Correlation to Treatment Outcome
por: Pedersen, Jannie, et al.
Publicado: (2013)

Hepatitis C prevalence in Denmark -an estimate based on multiple national registers
por: Christensen, Peer Brehm, et al.
Publicado: (2012)

Physicians' communication with patients about adherence to HIV medication in San Francisco and Copenhagen: a qualitative study using Grounded Theory
por: Barfod, Toke S, et al.
Publicado: (2006)

Length of stay in Denmark before HIV diagnosis and linkage to care: a population-based study of migrants living with HIV, Denmark, 1995 to 2020
por: Borchmann, Olivia, et al.
Publicado: (2022)

Four Weeks Treatment with Glecaprevir/Pibrentasvir + Ribavirin—A Randomized Controlled Clinical Trial
por: Madsen, Lone W., et al.
Publicado: (2022)

Characterization of a Novel Hepatitis C Virus Genotype 1 Subtype from a Patient Failing 4 Weeks of Glecaprevir-Pibrentasvir Treatment
por: Pedersen, Martin S., et al.
Publicado: (2021)

Hepatitis C prevalence in Denmark in 2016—An updated estimate using multiple national registers
por: Nielsen, Stine, et al.
Publicado: (2020)

Mortality among Patients with Cleared Hepatitis C Virus Infection Compared to the General Population: A Danish Nationwide Cohort Study
por: Omland, Lars Haukali, et al.
Publicado: (2011)

Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections—A Scandinavian real-life study
por: Dalgard, Olav, et al.
Publicado: (2017)

Lipid Droplets Accumulation during Hepatitis C Virus Infection in Cell-Culture Varies among Genotype 1–3 Strains and Does Not Correlate with Virus Replication
por: Galli, Andrea, et al.
Publicado: (2021)

Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation
por: Elmholdt, Tina R., et al.
Publicado: (2013)

Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19
por: Underwood, Alexander P., et al.
Publicado: (2021)

Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication
por: Ramirez, Santseharay, et al.
Publicado: (2021)

Eosinophilic oesophagitis in Denmark: Population‐based incidence and prevalence in a nationwide study from 2008 to 2018
por: Allin, Kristine Højgaard, et al.
Publicado: (2022)

SARS-CoV-2 seroprevalence among 7950 healthcare workers in the Region of Southern Denmark
por: von Huth, Sebastian, et al.
Publicado: (2021)

Nationwide trends in glucose-lowering drug use, Denmark, 1999–2014
por: Christensen, Diana Hedevang, et al.
Publicado: (2016)

Geographical Variation in Use of Intensive Care in Denmark: A Nationwide Study
por: Vestergaard, AHS, et al.
Publicado: (2015)

Analysis of Neutralization Titers against SARS-CoV-2 in Health-Care Workers Vaccinated with Prime-Boost mRNA–mRNA or Vector–mRNA COVID-19 Vaccines
por: Sølund, Christina, et al.
Publicado: (2022)

Novel HCV Genotype 4d Infectious Systems and Assessment of Direct-Acting Antivirals and Antibody Neutralization
por: Pham, Long V., et al.
Publicado: (2022)

Durability and breadth of neutralisation following multiple antigen exposures to SARS-CoV-2 infection and/or COVID-19 vaccination
por: Underwood, Alexander P., et al.
Publicado: (2023)

Changes over time in characteristics, resource use and outcomes among ICU patients with COVID‐19—A nationwide, observational study in Denmark
por: Haase, Nicolai, et al.
Publicado: (2022)

Outcomes in patients with chronic leg wounds in Denmark: A nationwide register‐based cohort study
por: Madsen, Ulla Riis, et al.
Publicado: (2021)

Trauma facilities in Denmark - a nationwide cross-sectional benchmark study of facilities and trauma care organisation
por: Weile, Jesper, et al.
Publicado: (2018)

Psoriasis and adverse pregnancy outcomes: A nationwide case-control study in 491,274 women in Denmark
por: Johansen, Cæcilie Bachdal, et al.
Publicado: (2022)

Sustained decline in tobacco purchasing in Denmark during the COVID-19 pandemic
por: Fosgaard, Toke R., et al.
Publicado: (2022)

Direct and indirect economic burden of lung cancer in Denmark a nationwide study
por: Gouliaev, Anja, et al.
Publicado: (2021)

Oral Polio Vaccination and Hospital Admissions With Non-Polio Infections in Denmark: Nationwide Retrospective Cohort Study
por: Sørup, Signe, et al.
Publicado: (2015)

Hepatitis C time trends in reported cases and estimates of the hidden population born before 1965, Denmark and Sweden, 1990 to 2020
por: Christensen, Peer Brehm, et al.
Publicado: (2022)

A Nationwide Observational Study of Chlamydia trachomatis Infections in Denmark during the COVID-19 Pandemic
por: HEDLEY, Paula L., et al.
Publicado: (2022)

A nationwide population‐based cohort study of the incidence of severe and rare infections among adults with psoriasis in Denmark
por: Loft, Nikolai, et al.
Publicado: (2022)

Prenatal Stress and Risk of Febrile Seizures in Children: A Nationwide Longitudinal Study in Denmark
por: Li, Jiong, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_abr80d99904c8e8lqpqpq8r25j